HOUSTON, May 20 (UPI) -- A U.S. study shows Gefitinib, a once-promising drug for treating lung cancer, can enhance hormonal therapy for treating some metastatic breast cancers.
... human experiment in which the outcome is unknown. These findings raise serious concerns about the potential interaction of the estrogenic dietary supplements with current breast cancer therapies."
... -dose synthetic estrogen was an accepted breast cancer therapy and was only abandoned when the estrogen-blocker tamoxifen ... called insulin-like growth factor-1 (IGF1).
"I think that in order for breast ...
...
Two other studies tested homeopathic medicines for relieving menopausal symptoms caused by breast cancer therapies. However, the researchers found no evidence in these studies for any benefit over ...
... I-SPY series is designed to accelerate and improve the efficiency with which experimental breast cancer therapies are assessed. The goals are to establish a clinical trials model that supports the ...
... method for proteomic profiling of MCF-7 breast cancer cells cultured in estradiol, a steroid ... drug commonly prescribed in hormonal breast cancer therapy.
The work resulted in the identification of 16 ...
... vaccines can meet a critical need in breast cancer therapy.
CT genes—the X denotes ... , strengthen and/or sustain immune responses against cancer. GlaxoSmithKline (GSK), which licensed MAGEA3 and NY- ...
... forward in potential breast cancer treatments.
"Improvements in breast cancer therapy have made prognoses ... cell survival process, apoptosis.
"Potential therapies would need to turn off this gene ...
... activity of Syk. "Our study shows that in normal breast cells, Syk is needed to control growth ... identify the molecules that Syk negatively regulates in order to target them for breast cancer therapy ...
... -receptor-positive stage 2 or 3 breast tumors, Ellis's group demonstrated that the post- ... easy to incorporate the test into standard breast-cancer therapy protocols. As soon as patients are diagnosed ...
... preprocessing and detection are ready for further miniaturization and integration in a single lab-on-chip platform. The system will be clinically validated in a breast cancer therapy study in Oslo.
... , especially in high-risk populations, and monitoring the response to antiestrogen breast cancer therapies such as aromatase inhibitors. It could also help in monitoring hormone levels in infertility ...
